Safety and Efficacy Extension Study of Daclizumab High Yield Process (DAC HYP) (BIIB019) in Participants Who Have Completed Study 205MS202 (NCT00870740) to Treat Relapsing Remitting Multiple Sclerosis
Clinical trial NCT01051349 · COMPLETED
Trial details
- NCT number
- NCT01051349
- Sponsor
- Biogen
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2010-03-31
- Primary completion
- 2016-08-25
- Enrollment
- 410
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.